Nayanthara - Vignesh Shivn efforts pays dividends -Koozhangal gets The New Yorker's pat

Chennai,April30 : Apart from usual news of jet setting by  Nayanthara and beau Vignesh, -  Their production house Rowdy Pictures Pvt Ltd backed  Koozhangal ( Pebbles) the Tamil film has been adjudged the best film of  a new director by film critic Richard Brody ,under the category New Directors/New Films series (which runs from April 28th to May 8th, both online and in person).. This was mentioned in the The New Yorker online portal by the film critic. He tweeted -Pebbles, directed by P.S. Vinothraj, is the one essential, unmissable dramatic feature I've seen in @NDNF  which starts tomorrow; it's further proof that observation is inseparable from imagination, aesthetics from substance:

About director Vinothraj film making he writes - Vinothraj films the women’s work in intimate detail and at awestruck length, showing exactly what a mere cupful demands of them. It’s among the most memorable endings in recent cinema.

He writes - "Vinothraj’s passion for detail is analytical—it’s a passion for infrastructure, for the conditions of mere subsistence, and for the menace and despair that those conditions impose. (In another scene, he painstakingly films a different family’s poignantly ingenious schemes to catch and eat rats.)"

Richard is movies editor for Goings On About Town and the author of “Everything Is Cinema: The Working Life of Jean-Luc Godard.”. He started writing for The New Yorker since 1999 and  writes about movies in his blog, The Front Row. 

Koozhangal is only the second Indian movie to win the Tiger Award after Sanal Kumar Sasidharan’s Sexy Durga in 2017 in International Rotterdam Film Fest.

The film would have been among the many films that started  with gusto and little money to end up a dream half completed. Lean and Teach Production House members who felt that Vinothraj had the stuff after seeing his short films backed the project. Half way through, it ran out of money. It was placed in the Film Baazar of IFFI Goa (2019) asking for co= producers. Director Ram whose film Peranbu and Taramani are most talked Tamil films saw the film work. He got excited seeing the output. He took it to Yuvan to score a BGM ( it has no songs), next he suggested a few changes and reshoots. From there he took it to Vignesh Shivn who with Nayanthara had floated a production house. Rest is history.

Bigg Boss 3 Malayalam contestant Dimpal's father body cremation in Delhi to wait for space

 

Chennai, April 29 :  Bigg Boss 3 Malayalam contestant Dimpal Bhal's father's cremation is facing delay as there is scarcity of space in crematoriums, said a source in New Delhi. Asianet channel which is part of Star - Disney network is using all channels to get a speedy nod.  

Dimpal's father Satyavir Singh Bhal, a native of Meerut , is resident of Delhi. He was undergoing treatment for respiratory and cardiac problems. On April 27 , he took ill and died on the way to the hospital. His body was tested for covid 19 and was found negative.

Sathyavir Singh Bhal lives in New Delhi with his youngest daughter Nayan and his wife Mini along with her daughter Simple and Dimpal lives in Kattappana ( Kerala). The news of Dimple Bhal's father death was at first confirmed by Lakshmi Jayan, ex contestant and one of the first to get eliminated from the show. Later Bhanu, recently eliminated from the show and one who developed close bond with Dimpal in Bigg Boss House confirmed it. Later Simple took to Instagram Live to break the news. Sources said that Dimpal left Chennai Airport yesterday and reached Delhi. Her mother and sister Simple too reached from Kochi. 

Like in Bigg Boss 4 Tamil, a contestant's father passes away in Bigg Boss 3 Malayalam reality show telecast on Asianet. Those who watched Bigg Boss  4 (Tamil) recalled the exit of Anitha Sampath, a TV news presenter from the show on hearing about her father's death. Both the contestants were in the last four weeks of the contest and strong contenders to the title.

Dimpal had in the yesterday episode told the BB camera that she was happy to complete the task as it required a lot of running. As a cervical cancer survivor, Dimpal is not to undertake any task that puts a strain on her cervical region. She said that she had told her father once about her desire to run in the track field and her father said in Hindi - Sapna dekhthe  raho uske liye koi izzazath nahi chaiye ( Keep dreaming, for that you do not need any permission).

As the reality show reached the last 30 days of the 100 days, a contestant openly voiced the opinion of many other contestants who think that Dimple is using the cancer survivor card to get audience sympathy. It led to severe backlash from various NGO's and fans of Dimpal. Host - actor Mohanlal pulled up the contestant, who offered to quit the show and publicly apologised for his utterance.

In today's episode, one of the contestant Manikuttan, a close pal of Dimpal makes his re-entry . He abruptly left the show and left Dimpal in tears. His entry would no doubt cheer her but to only plunge her in grief later in the day.

When Power Star turned Politician fails to power the Box Office - Pawan Kalyan

 

Chennai, April 28; The most talked about gup shup in Hyderabad is about everybody deserting Pawan Kalyan the POWER STAR after the debacle of Vakeel Saab . Talk is that  except the producer of an upcoming film nobody was even near the actor when he was admitted in the hospital. Political circles are abuzz that BJP after taking advantage of Pawan's Janasena party in the Hyderabad civic polls  ditched him after the beating at the box office.

The Jubilee Hill guys are wondering as to where the big brother great Chiru and his clan had vanished. The flop of Vakeel Saab is not the first in his career. This flop has more significance to his future as it also reflects on his political journey . The path he has charted seems to be a path to isolation from filmdom and politics. The very lone tusker attitude in filmdom and in public life as well his simplicity and frankness adhered him to the youth of the early 2000's.

Today ten years later, his BJP alliance has created a rift in his fan base , which should be by a rough estimate in their late forties or fifties.  The  rise of YSR and KCR has put Pawan in a spot as they seem to be more attractive as politicians to the actor's fan base.

As an industry watcher noted that when Pawan's films flopped earlier, the industry took it cooly and judged by the flaws in the making. Now it gets a mix of politically tainted response too and it does not help the actor.

To a hardcore Pawan fan, Vakeel Saab did not deliver the hit songs that he could be humming even if the flop flopped and that was the case for even the non Pawan fans.Johnny, gudumba shankar, balu, puli, teenmaar, panjaa, annavaram, bangaram had atleast 3-4 good songs that really made his fans to have expectations on each and every movie that released even after a flop. This made distributors go crazy about his movies, Vakeel Saab did not have that for his fans.

The lifestyle of an actor that is simple and his principles ( his party Janasena's moves and goals) made him a STAR that had surmounted his movie popularity and flops and hits no more matter, is what a die hard fan tells me. He says that nobody has a draw like Power Star in B&C centres and that the film is a profit and a bigger blockbuster abroad. Vested interests ( read political rivals and jealous family members) are spreading false rumours.

Fans are waiting for Pawan to recover from Covid 19 fatigue ( no idea what it means) and start work on remake of Ayyapanum Koshiyum Malayalam film with Rana. Also a period film with him playing a Robin Hood is on the floors.

Those who watched Pink should watch Vakeel Saab coming in Amazon on April 30 to know how films are tweaked to suit fan base of Power Star. Those who worked in Ayyapanum Koshiyum should watch to get an inkling of how their film would be tweaked for Power Star.

Love Life and Pakodi : A teenage love story told without frills ( Movie Review)

 Chennai, April27: Love- Life and Pakodi ( Telugu) is a love story of two youngsters who are grappling with the issue as to a legalised  marriage is needed to continue living and loving each other. Director Jayanth Gali tells the story as it is and conveys the feeling of the two youngsters towards this issue. He just leaves you to make the judgement and as he says in the end it is for the lovers to decide when they come across practical problems in our society.

The boy and the girl get together in rather a strange situation which many might not face. This bonds them further. They think alike and they are the bindaas type. Having sex and sharing an apartment has no issues. In fact, the girl loves him for the space that he gives and him being non judgemental about her.

Over a time, the boy develops the feeling that it is needed to get married to go further in their relationship. She is dumbfounded as to why this demand when everything is rosy. This moves creates a query in her mind about marriage. Things move on till it lands at the Registar office and she then tells her mind about what she thinks is life together without somebody uniting them on paper and her idea of what marriage is all about. You expect him to walk away but he says that his love for her makes him go along.

Without getting into a mushy romance or as the girl says Shah Rukh Khan style, it is a pleasant watch for elders too. The only twist in the tale of the boy's father and the girl's mother linkup was something that was filmy. It reminded me a K Balchander movie and the puzzle.

Actors Bimal Kartheek and Sanchitha Poonacha ( new finds) do well and film is technically good . 

Mohanlal's Marakkar for OTT -Telugu - Malayalam films most affected by Covid 19 second wave

Chennai, April 26 : Telugu industry has put off 4 film releases, Malayalam two , Kannada two and Tamil one due to second wave of Covid 19, says trade reports. Mammooty's One will release on Netflix tomorrow ( Apr 27) which will  be followed by Karthi's Sulthan on Hotstar May 2, Dhanush Karnan on Amazon -May 7th, Operation Jawa (Malayalam) on Zee5 - May 9th, Radhe Most Wanted - Salman Khan on Zee Plex on May 13th and Dhanush's Jagame Thanthiram on Netflix - June 18d. In between Sivakathikeyan Doctor is said to be heading for OTT release as it was to release on April 30th. In Telugu,Anasuya Bharadwaj’s Thank You Brother is the first Telugu film to go for OTT release amid second wave.Pawan Kalyan-starrer Vakeel Saab is set to premiere on Amazon Prime Video on April 30.

The Telugu films whose release dates have been postponed are Chiranjeevi - Acharya, Venkatesh Narappa ( Asuran remake).Love Story, Virata Parvam, Tuck Jagadish 4

Kannada film Adivi Shesh s Major  and KGF, Malayalam film Kurup starring Dulquar Salman and Arattu of Mohanlal were  May releases that are postponed.

Kerala trade circles say that Marakkar producer has started taking back advance given to theatres. This is seen as the producer heading for a OTT release if the pandemic situation worsens in May. Latest report says that the producer has given August 12 the release date.

Thalapathy Vijay Master and Suriya s Singam wipe out Star Vijay's Cook with Comali finale

Chennai, Apr24 : SunTV with Thalapathy Vijay Master premiere hit top of 15th week TRP  and backed by Singam release for Tamil New Years week. It has pushed Star Vijay further down in the top 5. The grand finale of Cook with Comali, highly rated reality show on Vijay TV had got in Stars like Simbhu onward for the finale but the Master of Vijay premiered diverted all eye balls to Sun. If two movies that come in top 5 are put in place, Star Vijay has only Bharathi Kannamma in this lineup. all others are Sun soaps.

Master might have washed out Star Vijay's hope to enter Cook with Comali finale in top 5 but Ajith fans are happy that it has not broken the record set up Viswasam. Master TRP of 17.10 and has registered 13755.46 impressions with its world television premiere. Viswasam- 18143000 impressions still is No 1 in TV premiere history.

One reason is that Master after theatre release is still available on Amazon.

Oral Antiviral CleVira Tablets gets Ayush Ministry clearance

 

Chennai Apr 22 : Apex laboratories private limited receives Government of India regulatory approval for Oral Antiviral CleVira Tablets, as a supporting measure for Mild to Moderate condition of COVID-19

• Manufacturing and Marketing approval granted for Clevira as a supporting measure for Mild to Moderate condition of COVID-19 as an additional indication in addition to its existing Antiviral approval.  

• Clevira has shown 86% recovery rate on the 5th day of treatment (86% Patients recovered – RT PCR – CT Value).

• 100% recovery on the 10th day of treatment. 

• Clinical recovery from all signs and symptoms in 4 days.

• One tablet twice daily dosing convenience of oral administration.  

• Safe on Liver and Kidney parameters.

Marking a landmark development in the fight against COVID-19 Pandemic in India and around the globe, apex Laboratories Private Limited ,a Chennai based Pharmaceutical manufacturer and exporter known for Research, Innovation and quality medicines for more than four decades, today announced the approval of Antiviral drug Clevira as a supporting measure for Mild to Moderate condition of COVID-19.

apex laboratories private limited has received approval from Government of India (Ministry of AYUSH) regulators, for their Anti-Viral Drug Clevira as an additional indication as a supporting measure for Mild to Moderate condition of COVID-19 making it first of its kind approval in India through various stages of scrutiny at CCRAS (The Central Council for Research in Ayurvedic Sciences) and Inter Disciplinary Technical Review committee (ITRC) a 12 member technical committee constituted by Ministry of AYUSH and headed by Dr.S.K.Maulik Former Professor Department of Pharmacology AIIMS.

Clevira is the brain child of apex’s R&D Center based on proven scientific evidence and was launched in Indian market during the recent outbreak of Dengue epidemic and associated mortality in 2017. Clevira is extensively studied for its safety in animal model (Wistar rats) and efficacy in Human subjects in Phase II and III clinical trials. Clevira is an approved Antiviral formulation for the treatment of various viral infections including viral fever associated with or without thrombocytopenia. Clevira has proven for its efficacy as Analgesic, Antipyretic and reversal of thrombocytopenia apart from its Antiviral property. 

A phase III Clinical trial was carried out in Government Medical Collage Omandurar Govt. Estate Chennai, based on Government approval from The State Government of Tamil Nadu. The trial outcomes revealed that Clevira has shown 86% recovery rate on 5th day of treatment in Mild to Moderate COVID-19. 100% recovery rate noticed on 10th day of treatment. Clinical recovery from all signs and symptoms was registered in          4 days. Clevira is proven to be safe on Kidney and Liver parameters.

The study outcomes were placed before the Government of Tamil Nadu, Indian Council of Medical Research (ICMR) and Ministry of AYUSH in 2020. After various stages of scrutiny and deliberations before various technical review committees, Government of India (Ministry of AYUSH) regulators have granted approval for Clevira as a supporting measure for Mild to Moderate condition of COVID-19.    

Clevira is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. 

About apex laboratories private limited 

apex laboratories private limited is more than 4 decades old Pharmaceutical manufacturer and exporter based at Chennai India, known for its flagship brands such as Zincovit, P range of Paracetamol and a whole range of branded formulations including dermatology, having global presence in over 30 countries. Research, Innovation and quality are the guiding principles of apex. It is ranked among top 50 Indian pharmaceutical companies. For more information visit www.apexlab.com

References:

1. CTRI/2020/05/025483

2. Ramesh Kannan S et al, International Journal of Innovative Research in Medical Science , Vol 04, Issue 09,Oct 2019

3. http://www.apexlab.com/preview-Clevira-tablets.php